肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

布鲁顿酪氨酸激酶(BTK)在INA6骨髓瘤细胞生长和转移中的作用

Role of Bruton’s tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells

原文发布日期:2014-08-01

DOI: 10.1038/bcj.2014.54

类型: Original Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

布鲁顿酪氨酸激酶(BTK)在INA6骨髓瘤细胞生长和转移中的作用

Role of Bruton’s tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells

原文发布日期:2014-08-01

DOI: 10.1038/bcj.2014.54

类型: Original Article

开放获取: 是

 

英文摘要:

Bruton’s tyrosine kinase (BTK) and the chemokine receptor CXCR4 are linked in various hematologic malignancies. The aim of the study was to understand the role of BTK in myeloma cell growth and metastasis using the stably BTK knockdown luciferase-expressing INA6 myeloma line. BTK knockdown had reduced adhesion to stroma and migration of myeloma cells toward stromal cell-derived factor-1. BTK knockdown had no effect on short-term in vitro growth of myeloma cells, although clonogenicity was inhibited and myeloma cell growth was promoted in coculture with osteoclasts. In severe combined immunodeficient-rab mice with contralaterally implanted pieces of bones, BTK knockdown in myeloma cells promoted their proliferation and growth in the primary bone but suppressed metastasis to the contralateral bone. BTK knockdown myeloma cells had altered the expression of genes associated with adhesion and proliferation and increased mammalian target of rapamycin signaling. In 176 paired clinical samples, BTK and CXCR4 expression was lower in myeloma cells purified from a focal lesion than from a random site. BTK expression in random-site samples was correlated with proportions of myeloma cells expressing cell surface CXCR4. Our findings highlight intratumoral heterogeneity of myeloma cells in the bone marrow microenvironment and suggest that BTK is involved in determining proliferative, quiescent or metastatic phenotypes of myeloma cells.

 

摘要翻译: 

布鲁顿酪氨酸激酶(BTK)与趋化因子受体CXCR4在多种血液恶性肿瘤中存在关联。本研究旨在通过稳定敲除BTK的荧光素酶表达INA6骨髓瘤细胞系,探讨BTK在骨髓瘤细胞生长和转移中的作用。BTK敲除后,骨髓瘤细胞对基质细胞的粘附能力减弱,并向基质细胞衍生因子-1的迁移减少。尽管BTK敲除对骨髓瘤细胞的短期体外生长无影响,但克隆形成能力受到抑制,且在与破骨细胞共培养时促进了骨髓瘤细胞的生长。在对侧植入骨片的严重联合免疫缺陷-rab小鼠模型中,BTK敲除的骨髓瘤细胞在原发性骨骼中增殖生长增强,但向对侧骨骼的转移受到抑制。BTK敲除的骨髓瘤细胞改变了与粘附和增殖相关基因的表达,并增强了哺乳动物雷帕霉素靶蛋白信号通路。在176对临床样本中,从局灶性病灶纯化的骨髓瘤细胞BTK和CXCR4表达低于随机取样部位。随机取样样本中BTK的表达与细胞表面CXCR4表达的骨髓瘤细胞比例相关。我们的研究结果揭示了骨髓瘤细胞在骨髓微环境中的瘤内异质性,并表明BTK参与决定骨髓瘤细胞的增殖、静息或转移表型。

 

原文链接:

Role of Bruton’s tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……